Skip to main content

Table 1 Comparisons of the temperature changes in tumor, RSIs of BLI at day 14 post-treatment, and apoptosis rates between groups (* p < 0.01, ** p < 0.05)

From: The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model

 

Group B vs. C

Group B vs. D

Group C vs. D

Temperature changes

0.009*

0.009*

0.465

RSIs of BLI

0.834

0.047**

0.009*

Apoptosis rates

0.675

0.028**

0.008*

  1. Each number in the table indicates a p-value obtained by Mann–Whitney test.